Indications and safety of proton pump inhibitor drug use in patients with cancer

Author： Triadafilopoulos George   Roorda Andrew K   Akiyama Junichi  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.12, Iss.5, 2013-09, pp. : 659-672

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Guide to the Use of Proton Pump Inhibitors in Adult Patients

By Boparai Vandana   Rajagopalan Jaishree   Triadafilopoulos George  

Drugs, Vol. 68, Iss. 7, 2008-01 ,pp. : 925-947

Adis International

Access to resources Recommend Favorite

Polymorphism of CYP2C19 and Gastric Emptying in Patients with Proton Pump Inhibitor-resistant Gastric Ulcers

By Wada F   Murase K   Isomoto H   Soda H   Takeshima F   Omagari K   Mizuta Y   Tsukamoto K   Murata I   Kohno S  

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 413-421

Field House Publishing

Access to resources Recommend Favorite

Proton-Pump Inhibitor Therapy in Patients with Gastro-Oesophageal Reflux Disease: Putative Mechanisms of Failure

By Fass Ronnie  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1521-1530

Adis International

Access to resources Recommend Favorite

Drug-Drug Interaction Profiles of Proton Pump Inhibitors

By Ogawa Ryuichi   Echizen Hirotoshi  

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 509-533

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors

By Blume Henning   Donath Frank   Warnke André   Schug Barbara S.  

Drug Safety, Vol. 29, Iss. 9, 2006-01 ,pp. : 769-784

Adis International

Access to resources Recommend Favorite